Appili Therapeutics Inc. APLI.TO
Oct 2, 2026, 2:16 PM EDT
- YTD
- -80.00%
- 1 year
- -83.33%
- Market cap
- 4.24M
- Revenue (ttm)
- 827.41K
- EPS (ttm)
- -0.03
- Shares out
- 121.27M
- P/E ratio
- -0.16
- Forward P/E
- -0.88
- YTD return
- -80.00%
- 1-year return
- -83.33%
- Volume
- 117.00K
- Avg volume
- 119.27K
- Open
- 0.005
- Previous close
- 0.005
- Day's range
- 0.005 – 0.005
- 52-week range
- 0.025 – 0.06
- Beta
- 0.97
Key statistics
- Enterprise value
- 13.39M
- PEG ratio
- 0.00
- Price / sales
- 5.13
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -5.77M
- Total cash
- 301.26K
- Total debt
- 10.05M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.0357
- 200-day average
- 0.035813
Next earnings
Consensus EPS estimate 0.00.
About Appili Therapeutics Inc.
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Canada
- Website
- appilitherapeutics.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on APLI.TO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| The K2 Principal Fund L.P. | 10% Security Holder of Issuer | Acquisition or disposition in the public market | Nov 28, 2021 | 5,301,101 |